Feb 19, 2018 - Overblown toxic stocks are generally susceptible to outside shocks and are loaded with a huge amount of debt.
Feb 16, 2018 - The tiny pharma stock received an upgrade from a prominent analyst.
Feb 15, 2018 -
Feb 15, 2018 - Incyte (INCY) beat on revenues in the fourth quarter driven by an increase in Jakafi sales. The guidance for 2018 was also encouraging.
Feb 15, 2018 - Incyte (INCY) beat on sales in the fourth quarter driven by growth in Jakafi sales.
Feb 13, 2018 - This small biotech stock is a high-risk but potentially high-reward proposition.
Feb 12, 2018 - Growth in Jakafi sales are likely to help Incyte (INCY) to beat on earnings in Q4.
Feb 09, 2018 - Although Prothena's (PRTA) track record is good, the company is unlikely to beat estimates in the current quarter given the unfavorable rank and Earnings ESP.
Feb 06, 2018 - Total earnings for the medical sector are up 16.9% from the same period last year on 8.5% higher revenues so far.
Feb 02, 2018 - AstraZeneca (AZN) beats earnings estimates in fourth quarter on higher product revenues.